142 related articles for article (PubMed ID: 15794861)
1. Clinical characteristics and outcome of immunoglobulin M-related disorders.
Cesana C; Barbarano L; Miqueleiz S; Lucchesini C; Ricci F; Varettoni M; Filippini D; Lazzarino M; Morra E
Clin Lymphoma; 2005 Mar; 5(4):261-4. PubMed ID: 15794861
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
Morra E; Cesana C; Klersy C; Barbarano L; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Miqueleiz S; Bernuzzi P; Nosari AM; Lazzarino M
Leukemia; 2004 Sep; 18(9):1512-7. PubMed ID: 15322559
[TBL] [Abstract][Full Text] [Related]
3. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
Morra E; Cesana C; Klersy C; Varettoni M; Cavanna L; Canesi B; Tresoldi E; Barbarano L; Lazzarino M;
Semin Oncol; 2003 Apr; 30(2):172-7. PubMed ID: 12720131
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies.
Morra E; Cesana C; Klersy C; Barbarano L; Miqueleiz S; Varettoni M; Lucchesini C; Ricci F; Lazzarino M
Clin Lymphoma; 2005 Mar; 5(4):265-9. PubMed ID: 15794862
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
Greco A; Tedeschi A; Varettoni M; Nichelatti M; Paris L; Ricci F; Vismara E; Morra E
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):77-9. PubMed ID: 21454196
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders.
Pangalis GA; Kyrtsonis MC; Kontopidou FN; Siakantaris MP; Dimopoulou MN; Vassilakopoulos TP; Tzenou T; Kokoris S; Dimitriadou E; Kalpadakis C; Tsalimalma K; Tsaftaridis P; Panayiotidis P; Angelopoulou MK
Clin Lymphoma; 2005 Mar; 5(4):235-40. PubMed ID: 15794855
[TBL] [Abstract][Full Text] [Related]
8. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.
Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA
Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
Kyle RA; Ansell SM; Kapoor P
Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
[TBL] [Abstract][Full Text] [Related]
10. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
[TBL] [Abstract][Full Text] [Related]
11. Emergence of immunoblastic sarcoma in Waldenstrom's macroglobulinemia.
Leonhard SA; Muhleman AF; Hurtubise PE; Martelo OJ
Cancer; 1980 Jun; 45(12):3102-7. PubMed ID: 6770989
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
Baldini L; Goldaniga M; Guffanti A; Broglia C; Cortelazzo S; Rossi A; Morra E; Colombi M; Callea V; Pogliani E; Ilariucci F; Luminari S; Morel P; Merlini G; Gobbi P
J Clin Oncol; 2005 Jul; 23(21):4662-8. PubMed ID: 16034042
[TBL] [Abstract][Full Text] [Related]
13. Waldenström's macroglobulinemia.
Gertz MA; Fonseca R; Rajkumar SV
Oncologist; 2000; 5(1):63-7. PubMed ID: 10706651
[TBL] [Abstract][Full Text] [Related]
14. B-cell malignant lymphoma associated with monoclonal macroglobulinemia and cryoglobulinemia.
Nozaki H; Tanaka K; Shimizu M; Komatsuda M; Tsutsumi Y; Arimori S
Tokai J Exp Clin Med; 1988 Dec; 13(4-5):245-51. PubMed ID: 3151523
[TBL] [Abstract][Full Text] [Related]
15. [Lymphoplasmacytic lymphoma with Waldenström's macroglobulinemia: a clinicopathological and immunophenotypic study of 40 Chinese patients].
Liang DN; Li GD; Dai L; Huang J; Wang WY; Feng WH; Li FY; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):728-32. PubMed ID: 20079010
[TBL] [Abstract][Full Text] [Related]
16. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
17. B-cell neoplasms with homogeneous cold-reacting antibodies (cold agglutinins).
Crisp D; Pruzanski W
Am J Med; 1982 Jun; 72(6):915-22. PubMed ID: 6807086
[TBL] [Abstract][Full Text] [Related]
18. IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia.
Zarrabi MH; Stark RS; Kane P; Dannaher CL; Chandor S
Am J Clin Pathol; 1981 Jan; 75(1):1-10. PubMed ID: 6779622
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
[TBL] [Abstract][Full Text] [Related]
20. Waldenström's macroglobulinemia: review of 45 cases.
Krajny M; Pruzanski W
Can Med Assoc J; 1976 May; 114(10):899-900, 902, 905. PubMed ID: 817791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
